Results 131 to 140 of about 4,071 (233)

Fluocinolone acetonide 0.2 μg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]

Background: Non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) is an inflammatory disease, which can significantly impair visual acuity if not adequately treated.
Bodaghi Bahram, Burke Tomás, Devonport Helen, Heinz Carsten, Kodjikian Laurent, Llorenç Víctor, Miserocchi Elisabetta, Nogueira Vanda, Pavesio Carlos, Pleyer Uwe   +9 more
core   +1 more source

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]

Clinical Ophthalmology, 2020
Kasserine Taylor,1 Michael W Stewart2 1Department of Ophthalmology, Mayo Clinic Florida, Jacksonville, FL, USA; 2Cornell University, Ithaca, NY, USACorrespondence: Michael W StewartDepartment of Ophthalmology, Mayo Clinic Florida, 4500 San Pablo Road ...
Taylor K, Stewart MW
doaj  

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)

International Medical Case Reports Journal, 2020
Bernardete Pessoa,1,2 João Melo-Beirão,1,2 Angelina Meireles,1,2 Pedro Menéres1,2 1Ophtalmology Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Unit for Multidisciplinary Research in Biomedicine ...
Pessoa B, Melo-Beirão J, Meireles A, Menéres P   +3 more
doaj  

A novel intravitreal fluocinolone acetonide implant (Iluvien®) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series

Clinical Ophthalmology, 2015
Vera K Schmit-Eilenberger Augenklinik Städtisches Klinikum, Karlsruhe, Baden-Württemberg, Germany Background: Iluvien® is a novel, nonbiodegradable, sustained-release drug delivery system (0.2 µg/d fluocinolone acetonide [FAc ...
Schmit-Eilenberger VK
doaj  

Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease [PDF]

, 2017
Background: The evidence on the use of dexamethasone implants in the treatment of Behçet’s disease (BD)-related uveitis is limited to a few cases. Objectives: To evaluate the efficacy of dexamethasone implants on ocular functional, morphological, and ...
Bacherini, Daniela, Cantarini, Luca, Emmi, Giacomo, Fabiani, Claudia, Franceschini, Rossella, Frediani, Bruno, GUERRIERO, Silvana, IANNONE, Florenzo, LOPALCO, GIUSEPPE, Marco Tosi, Gian, Rigante, Donato, Vannozzi, Lorenzo   +11 more
core  

Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant [PDF]

Eye, 2009
J L Sims, S P Chee
openaire   +1 more source

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months [PDF]

Purpose: This study assessed the effectiveness of the 0.19-mg fluocinolone acetonide (FAc) implant by multimodal measurements in patients with non-infectious uveitis (NIU) in a real-world setting in Spain.
Adán Civera, Alfredo, Coelho Borges, Ana Isabel, Hernanz, Inés, Llorenç, Victor, Moll Udina, Aina, Pazos, Marta, Pelegrín, Laura, Sainz de la Maza Serra, María Teresa   +7 more
core   +1 more source

Efficacy of 0.19 mg Fluocinolone Acetonide Implant in Non-infectious Posterior Uveitis Evaluated as Area Under the Curve. [PDF]

Ophthalmol Ther, 2022
Battista M, Starace V, Cicinelli MV, Capone L, Marchese A, Modorati G, Bandello F, Miserocchi E.   +7 more
europepmc   +1 more source

Real-World Outcomes in Diabetic Macular Edema for the 0.2 µg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK. [PDF]

Clin Ophthalmol, 2021
Mushtaq B, Bhatnagar A, Palmer H.
europepmc   +1 more source

Intraocular Pressure Changes Are Predictive of Ocular Hypertension Onset After Fluocinolone Acetonide Implant: Significant Cutoffs and the Role of Previous DEX Implant. [PDF]

Front Med (Lausanne), 2021
Arrigo A, Aragona E, Capone L, Di Biase C, Lattanzio R, Bandello F.   +5 more
europepmc   +1 more source